RankAlpha logo
Back to Rankings

SPRO

Spero TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
SPRO vs peer average
32/100
SPRO vs. peer average (F vs. D)
Grade spread
A 1 · C 2 · D 1 · F 4
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

ATHE is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $83.27M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerATHEAlteriry Therapeutics
SPRO
Spero Therapeutics
ATHE
Alteriry Therapeutics
Grade
F
F
Momentum
5
13
Value
56
41
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs ATHE

SPRO / ATHE
Grade Position
Below peers
SPRO vs. peer average (F vs. D)
32/100
Momentum
5
ATHE
Value
56
SPRO
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs SPRO
1
ATHE
Alteriry Therapeutics Ltd ADR
F
20/100
Even
2
SERA
Sera Prognostics Inc Class A Common
F
20/100
Even
3
CSBR
Champions Oncology Inc Common
C
60/100
-2
4
NTHI
NeOnc Technologies Holdings Inc Common
F
20/100
Even
5
CGTX
Cognition Therapeutics Inc Common
C
60/100
-2
ATHE is the first peer returned for this comparison set.